Alteogen
Key metrics
Earnings
| Revenue, Q3 2026 | ₩119.8bn |
|---|---|
| Revenue QoQ | +73.9% |
| Revenue YoY | +144.4% |
| Operating income, Q3 2026 | ₩78.9bn |
| Operating income QoQ | +130.8% |
| Operating income YoY | +195.8% |
Share buybacks
| Buyback decided, last 3 months | ₩0 |
|---|---|
| Buyback decided, last 3 months, % of shares | 0.0% |
| Shares acquired, last 3 months | ₩0 |
| Shares acquired, last 3 months, % of shares | 0.0% |
| Treasury shares cancelled, last 3 months | ₩0 |
| Treasury shares cancelled (number), last 3 months | 0 shares |
| Treasury shares cancelled, last 3 months, % of shares | 0.0% |
| Buyback decided, last 12 months | ₩0 |
| Buyback decided, last 12 months, % of shares | 0.0% |
| Shares acquired, last 12 months | ₩0 |
| Shares acquired, last 12 months, % of shares | 0.0% |
| Treasury shares cancelled, last 12 months | ₩0 |
| Treasury shares cancelled (number), last 12 months | 0 shares |
| Treasury shares cancelled, last 12 months, % of shares | 0.0% |
Potential dilution
| CB/BW/EB issued, last 12 months | ₩0 |
|---|---|
| Rights offering new shares, last 12 months | 731,078 shares |
| Potential new shares, last 12 months | 731,078 shares |
| Potential new shares, % of shares | 1.4% |
| Conversion price adjustments, last 12 months | 0 |
Supply contracts
| Supply contracts, last 12 months | ₩0 |
|---|---|
| Supply contracts vs prior-year revenue | 0.0% |
| Contracts without a KRW amount | 0 contracts without a KRW amount excluded |
Disclosure activity
| DART filings, last 3 months | 14 |
|---|---|
| DART filings, previous 3 months | 17 |
Insider transactions
| Open-market buys, last 12 months (shares) | 0 shares |
|---|---|
| Open-market buys, last 12 months (amount) | ₩0 |
| Open-market sells, last 12 months (shares) | 0 shares |
| Open-market sells, last 12 months (amount) | ₩0 |
| Net open-market buying, last 12 months (shares) | 0 shares |
| Insiders who bought, last 12 months | 0 |
Insider transactions (last 12 months)
Open-market buys: 0 shares (₩0). Open-market sells: 0 shares (₩0). Net open-market buying: 0 shares. Insiders who bought: 0.
| Trade date | Insider (role) | Type | Shares | Price | Amount | |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | Kim Hang-yeon (Registered director) | Other (Stock option exercise) | +3,900 shares | — | — | |
| Aug 6, 2026 | Park Sun-jae (Registered director, 10%+ shareholder) | Other (Bonus shares) | +3,061,800 shares | — | — | |
| Aug 6, 2026 | Jeon Tae-yeon (Registered director) | Other (Bonus shares) | +2,160 shares | — | — | |
| Aug 6, 2026 | Kim Hang-yeon (Registered director) | Other (New report) | +3,000 shares | — | — | |
| Aug 6, 2026 | Kim Hang-yeon (Registered director) | Other (Bonus shares) | +900 shares | — | — | |
| Aug 6, 2026 | Ko In-yeong (Registered director) | Other (Bonus shares) | +15 shares | — | — |
Annual financials
| Year | Revenue | Operating income |
|---|---|---|
| 2025 | ₩215.9bn | ₩106.9bn |
| 2024 | ₩102.9bn | ₩25.4bn |
| 2023 | ₩96.5bn | -₩9.7bn |
Filing timeline
-
Alteogen third-party rights offering of 191,473 new shares for ₩50.0bn
Alteogen filed a rights offering of 191,473 new shares through third-party allotment, raising ₩50.0bn. The stated main purpose of the funds is operating funds. The new shares equal 0.3% of existing shares, and the issue amount is 23.2% of FY2025 revenue by our calculation.
-
Alteogen third-party rights offering of 174,066 new shares for ₩50.0bn
Alteogen filed a third-party rights offering of 174,066 new shares to raise ₩50.0bn. The stated main purpose of the funds is operating funds, and the allocation method is third-party allotment. The new shares equal 0.2% of existing shares, and the issue amount is 23.2% of FY2025 revenue by our calculation.
-
Alteogen third-party rights offering of 191,473 new shares for ₩50.0bn
Alteogen filed a rights offering to issue 191,473 new shares through third-party allotment, raising ₩50.0bn. The stated main purpose of the funds is operating funds. The issue amount equals 23.2% of FY2025 revenue by our calculation.
-
Alteogen Rights Offering: 174,066 New Shares for ₩50.0bn
Alteogen filed a rights offering to issue 174,066 new shares through third-party allotment, raising ₩50.0bn. The company stated the main purpose of the funds is operating funds. The issue amount equals 23.2% of FY2025 revenue by our calculation.